Gilead Sciences Kicks Off 2023 With New Autoimmune Disease Alliance
Gilead Sciences has pledged billions of dollars to Galapagos in an autoimmune disease partnership that is far from expected. But the drugmaker is not giving up on this therapeutic area and is now forming a new alliance with a new partner whose technology could offer treatments for rheumatoid arthritis and lupus. The partner is EVOQ … Read more